The Latest Medical News

A Summary of The Latest Medical News: Here’s what we know so far about Moderna’s newly FDA-approved mRNA flu vaccine: 1. What happened • On May 10, 2024 the U.S. Food and Drug Administration granted full approval to Moderna’s mRNA influenza vaccine (known as mRNA-1010) for adults age 50 and older. • It’s slated to be offered for the 2026–2027 flu season in the United States. 2. Why it matters • Traditional flu shots use inactivated (killed) virus or viral proteins grown in eggs or cell culture. Moderna’s vaccine delivers messenger RNA encoding hemagglutinin – a key surface protein of circulating flu strains – prompting your own cells to make the protein and train your immune system. • mRNA vaccines can be updated more rapidly than egg-based vaccines, potentially improving the match to each season’s circulating influenza strains. • The technology has already been validated by the widespread use of mRNA COVID-19 vaccines. 3. How it works • The vaccine contains lipid nanoparticles that ferry mRNA into muscle cells. • Once inside, cells read the mRNA blueprint and build the flu hemagglutinin protein. • Your immune system recognizes this protein, develops antibodies, and “remembers” how to fight the real virus if you’re exposed later. 4. Potential advantages • Faster design and manufacturing turnaround—Moderna says it can have strain‐matched vaccines ready weeks sooner than egg-based methods. • No reliance on egg supply or cell‐culture scaling for each new season. • Early trial data suggest similar or better immune responses compared with standard quadrivalent flu shots. 5. Safety and side effects • In clinical trials in adults 50+, side effects were similar to other flu vaccines: injection-site soreness, fatigue, headache, muscle aches. • Serious adverse events were rare. The FDA‘s review confirms that benefits outweigh risks in the approved age group. 6. Next steps & what to expect • Moderna will scale up manufacturing and work with the Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices (ACIP) on dosing recommendations. • If you’re 50 or older, look for this new mRNA option when you get your flu shot in fall 2026. Your healthcare provider or pharmacist will let you know which formulation they’re offering. • People under age 50 are still recommended to get a standard quadrivalent flu vaccine each year. Bottom line: this marks the first licensed mRNA‐based flu vaccine in the U.S. It promises quicker updates to strain changes and potentially stronger protection for older adults. As always, check with your doctor or pharmacist about the best flu vaccine choice for you when the 2026–2027 season rolls around. Help with your insurance? https://tally.so/r/n012P9